We previously determined that metabolites associated with obesity activate PPARα signaling to modulate ERα activity in breast cancer cells [36], while PFAS activate PPARα to affect metabolism and the immune system [56]. This evidence concerns the gene PPARA and obesity due to melanocortin 4 receptor deficiency.